Search

Your search keyword '"Holmberg SD"' showing total 78 results

Search Constraints

Start Over You searched for: Author "Holmberg SD" Remove constraint Author: "Holmberg SD" Region united states Remove constraint Region: united states
78 results on '"Holmberg SD"'

Search Results

1. Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017.

2. Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C.

Catalog

Books, media, physical & digital resources

3. Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS).

4. Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States.

5. Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015.

6. Changing trends in complications of chronic hepatitis C.

7. A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.

8. Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma.

9. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012.

10. Hepatitis A Infections Among Food Handlers in the United States, 1993-2011.

11. Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

12. Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010.

13. Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs.

14. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study.

15. Estimating the Number of Patients Infected With Chronic HCV in the United States Who Meet Highest or High-Priority Treatment Criteria.

16. Decline in hepatitis E virus antibody prevalence in the United States from 1988-1994 to 2009-2010.

17. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

18. Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study.

19. Racial disparities in the proportion of current, unresolved hepatitis C virus infections in the United States, 2003-2010.

20. Reported reasons for testing among hepatitis B virus-infected patients - Chronic Hepatitis Cohort Study (CHeCS), United States, 2006-2010.

21. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.

22. Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010.

23. Estimating acute viral hepatitis infections from nationally reported cases.

24. Causes of death and characteristics of decedents with viral hepatitis, United States, 2010.

25. Hepatitis B testing and access to care among racial and ethnic minorities in selected communities across the United States, 2009-2010.

26. Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010.

27. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.

28. Hepatitis C in the United States.

29. Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009-2010.

30. Provider compliance with guidelines for management of cardiovascular risk in HIV-infected patients.

31. Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence.

32. Hepatitis C virus and the infectious diseases community.

33. Evolving epidemiology of hepatitis C virus in the United States.

34. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

35. Genotypic distribution of hepatitis B virus (HBV) among acute cases of HBV infection, selected United States counties, 1999-2005.

36. Is chronic hepatitis B being undertreated in the United States?

37. Hepatitis delta: seek and ye shall find.

38. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.

39. Molecular epidemiology of health care-associated transmission of hepatitis B and C viruses.

40. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).

41. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008.

42. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.

43. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

44. Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy.

45. State plans for containment of pandemic influenza.

46. Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities.

47. Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.

48. Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.

49. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women.

50. Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist care.